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The treatment of choice for the well differentiated thyroid 
carcinoma has always been controversial. Aim: to analyze 
tumor invasion of the thyroid gland’s contralateral lobe in 
cases of differentiated carcinoma, correlating risk/benefit with 
the complications of a second surgical approach. Materials 
and methods: Retrospective study, from 1998 to 2006, of 27 
patients undergoing less than total thyroidectomy: lobectomy 
(21), subtotal thyroidectomy (5) or isthmusectomy (1). Gender, 
age, type of surgery, complications, histopathological analysis 
and invasion of the contralateral lobe were analyzed. Patients’ 
ages varied from 17 to 89; the most frequent histopathological 
pattern was the classical papillary carcinoma (18 cases), 
followed by follicular carcinoma (6); the follicular variant of 
the papillary carcinoma (2) and the Hürthle cell carcinoma 
(1). Twenty-one patients underwent full thyroidectomies, 
from 15 to 30 days after the first intervention. Results: the 
contralateral lobe analysis was negative for carcinoma in 
16 (76.5%) and positive in the other 5 (23.8%) patients. 
The complications observed were temporary dysphonia (3 
cases) and hypoparathyroidism (2 cases, one permanent). 
Conclusions: total thyroidectomy is important in the 
treatment of differentiated thyroid carcinomas, because there 
is a high contralateral spread rate (23.8%). It is a procedure 
without mortality, which bears few complications.
Keywords: thyroid neoplasms, reoperation, thyroidectomy, 
thyroid gland.
original article
Braz J Otorhinolaryngol
2009;75(1):97-100.
98
Brazilian Journal of otorhinolaryngology 75 (1) January/feBruary 2009
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
INTRODUCTION
Surgical treatment of choice in thyroid differentiated 
carcinoma has always been a reason for controversy. Some 
authors advocate unilateral lobectomy and isthmectomy, 
since there is no difference in survival, when compared 
with total thyroidectomy, and it also reduces postoperative 
morbidity. Others have shown the advantages of subtotal 
thyroidectomy in the treatment of well differentiated car-
cinomas (removal of the entire affected side, isthmus and 
part of the contralateral lobe), because it would reduce 
the rate of local recurrence when compared to the patients 
submitted to a unilateral procedure. There are still authors 
who favor total thyroidectomy, because of the high per-
centage of contralateral lobe involvement and because it 
is a procedure with null mortality and a low incidence of 
complications1.
The finding of a bilateral malignant lesion in clini-
cally unilateral thyroid tumors grows in importance when 
we consider clinical and epidemiological stand point, as 
well as surgical and anatomopathological aspects. Such 
lesion or lesions located in the contralateral lobe and not 
diagnosed in the preoperative period (by semiotechnique 
and/or image exams) can be seen during the operation 
by the surgeon (through palpation), by the pathologist 
(during the frozen section intraoperative histopathology 
exam) or, as it happens most of the times, only during 
the final pathology exam, with the specimen already fixed 
in parafin2.
In the national literature, the data regarding the 
remaining thyroid tissue removal by completion thyroi-
dectomy in the second operation is limited, and there is 
no more specific analysis in this aspect. Moreover, most 
publications on this topic present extremely variable re-
sults, about the bilateral prevalence of malignancy from 
twenty all the way to eighty-eight percent2.
The goal of the present study was to analyze the 
pathology results of thyroidectomy completion in a single 
series of patients with unilateral thyroid differentiated car-
cinoma, and assess the potential complications that could 
occur from the second procedure.
MATERIALS AND METHODS
From 1998 to 2006, 36 patients with a diagnosis of 
thyroid carcinoma were operated. The study was approved 
by the Ethics Committee of the institution where it was 
carried out under protocol number 0282.0.147.000-07. Total 
thyroidectomy was performed as first intervention in nine 
patients (25%). In 21 patients (58.3%), the first intervention 
was lobectomy with isthmectomy, since these patients 
had a solid nodule at the preoperative neck ultrasound. 
Subtotal thyroidectomy was carried out in five patients 
(13.9%) because they had multinodular goiter in both 
thyroid lobes and the remaining patient was submitted 
to isthmectomy (2.8%), because this patient had a single 
nodule in the thyroid isthmus.
All the patients were assessed in the preoperative by 
means of ultrasound, fine needle aspiration of the nodule 
and lab tests to evaluate thyroid function.
Regarding the epidemiological profile of the pa-
tients initially submitted to unilateral surgery or to subtotal 
thyroidectomy, 23 patients were females (85.2%) and four 
were males (14.8%). Age varied between 17 and 89 years, 
with a mean value of 45 years.
The pathology analysis of the surgical specimens 
revealed the classic variant papillifera carcinoma in 18 
cases (66.7%), followed by follicular carcinoma in six cases 
(22.2%), follicular variant papillifera carcinoma (two cases 
- 7.4%) and Hurthle cells carcinoma in one case (3.7%). 
In all these patients a total thyroidectomy was indicated 
in a period that varied between 15 and 30 days after the 
first intervention.
Of the 27 patients studied, in six of them (22.2%) 
the completion thyroidectomy was not carried out; four 
refused the second operation, and we lost their follow up; 
in one there was intense fibrosis in the surgical field and 
the last one had a micro-carcinoma. Therefore, 21 patients 
were submitted to thyroidectomy completion.
RESULTS
The pathology analysis of the contralateral lobe of 
the surgical specimen was negative for carcinoma in 16 
(76.2%) and positive in the remaining five (23.8%) patients. 
In those whom the contralateral analysis was positive for 
carcinoma, the most frequently found histological pattern 
was the papillifera carcinoma in four, followed by follicular 
carcinoma in one (Figure 1).
Figure 1. Number of patients in relation to the pathology exam of the 
surgical specimen from the second surgical intervention.
In relation to post-operative complications, three 
patients (14.3%) had temporary dysphonia (one of them 
occurred in the first procedure and spontaneously reverted 
99
Brazilian Journal of otorhinolaryngology 75 (1) January/feBruary 2009
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
and the remaining two, after thyroidectomy complementa-
tion and reverted in 15 to 40 days). Another complication 
after thyroidectomy completion was hypoparathyroidism, 
which happened to two patients (9.5%), temporary in one 
- lasting for 35 days, and permanent in another. There was 
zero mortality.
DISCUSSION
Most of the series studied have advocated total 
thyroidectomy for the surgical treatment of the thyroid di-
fferentiated carcinoma, simply because this procedure has 
advantages, such as: a greater sensitivity regarding the level 
of thyroglobulin to assess the recurrent disease, especially 
distant ones; ease of detection and ablation for distant me-
tastasis by radiotherapy; prevent the possibility of residual 
thyroid differentiated carcinoma to turn anaplastic; and 
greater survival with a lower rate of recurrence3-14.
Some series have shown that the possibility of the 
patient having residual tumor in the contralateral lobe 
is variable, from 21 to 62%, when total thyroidectomy is 
carried out for prophylaxis purposes6,9,12,15. De Jong et al. 
Showed an incidence of 43% of contralateral lobe involve-
ment in 100 patients; Kim et al.16 showed an incidence of 
31% in 81 patients and Pacini et al.17, showed an incidence 
of 44% in 80 patients. These data match the ones in our 
series, which was of 23.8% (five in 21 patients).
Multicentricity in the primary lobe seems to be as-
sociated with the higher incidence of bilateral carcinoma, 
as it has been shown by other authors12,18. Although this 
statement can be true, none of our patients had a multifocal 
primary lobe lesion. Since it was shown that the inciden-
ce of latent carcinoma could be high, the issue is what 
method would be safer in order to remove the remaining 
contralateral lobe without causing higher morbidity. Some 
authors believe the reoperation can be associated with a 
higher morbidity and thus have advocated ablation with 
radioactive iodine of the remaining thyroid tissue in lieu 
of completion thyroidectomy19. However, this procedure 
is challenged by many, because it has some disadvan-
tages, such as the need for a high dose of radioactive 
iodine, long term development of parathyroid adenoma 
and teratogenicity in young women in their reproductive 
years6,20-22. Thus, thyroidectomy completion has, once 
more, its importance and, if carried out by a competent 
team, carries low morbidity. Among the complications 
mentioned, dysphonia as a consequence of the recurrent 
laryngeal nerve involvement has been found in an inciden-
ce of 0 to 5%4,6,7,9,10,12. However, in most cases, dysphonia 
is transitory, as it happened in our series. Although the 
incidence of this complication has been greater than the 
average expected in the literature - 14.3% in a study group 
of 27 patients -three patients recovered their voices in 15 
to 40 days of postoperative, without showing any vocal 
fold sequelae, confirmed by laryngoscopy.
Another complication that has enjoyed some at-
tention is hypoparathyroidism which, in our series, was 
present in 9.5% of the cases, matching the literature infor-
mation, which varies from 0 to 16.8%3,4,6,7,9,12. In one case, 
this complication was temporary, it reverted 35 days later 
with specific treatment, and such fact was shown by other 
authors4,6,9. De Jong et al. showed that hypoparathyroidism 
was present in 3% of the patients who were submitted to 
total completion thyroidectomy and used vitamin D and 
calcium for some months with clinical signs and symptoms 
reversion.
Despite the incidence below 3%, some authors, 
even those who favor thyroidectomy completion, have 
advocated surgical procedure interruption when there 
is too much fibrosis in the operating field, in order to 
avoid complications. Such fact happened to one of our 
patients, but we were unable to follow him up. Although 
some authors9 indicate that the thyroidectomy completion 
should be carried out between three and six months of 
the first surgical intervention in order to prevent compli-
cations, this is not what we advocate, in agreement with 
Kim et al.16, who indicate the second intervention as early 
as possible, as a means to reduce the chance of hemato-
genic and lymphatic spread of the residual tumor to the 
contralateral lobe of these patients. The cases studied 
were operated in the first 30 days of postoperative from 
the first intervention, and such fact also occurred in other 
series studied4,6,10,12.
CONCLUSIONS
Thyroidectomy completion is an important procedu-
re in the treatment of a malignant thyroid tumor because 
of the high rate of contralateral involvement (23.8%). It is 
a procedure with zero mortality and very low complication 
rate, not bearing relevant risks. 
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